Table 1.
STR profiles of HeLa lines
| Trial identification | Reported name | Comparison with consensus | Percent match | SGM profile results
|
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| amg | D18S1179 | D21S11 | D8S1179 | FGA | TH01 | vWF | |||||
| Consensus profile |
X | 16 | 27, 28 | 12, 13 | 18, 21 | 7 | 16, 18 | ||||
| 1 | 43 | HeLa | Identical | 100 | X | 16 | 27, 28 | 12, 13 | 18, 21 | 7 | 16, 18 |
| 2 | 229 | HeLa | Identical | 100 | X | 16 | 27, 28 | 12, 13 | 18, 21 | 7 | 16, 18 |
| 3 | 243 | HeLa | Identical | 100 | X | 16 | 27, 28 | 12, 13 | 18, 21 | 7 | 16, 18 |
| 4 | 162 | HeLa S3 | Identical | 100 | X | 16 | 27, 28 | 12, 13 | 18, 21 | 7 | 16, 18 |
| 5 | 181 | HeLa S3 | Identical | 100 | X | 16 | 27, 28 | 12, 13 | 18, 21 | 7 | 16, 18 |
| 6 | 169 | Hep II | Identical | 100 | X | 16 | 27, 28 | 12, 13 | 18, 21 | 7 | 16, 18 |
| 7 | 254 | Intestine 407 | Identical | 100 | X | 16 | 27, 28 | 12, 13 | 18, 21 | 7 | 16, 18 |
| 8 | 14H | HPC36M | Identical | 100 | X | 16 | 27, 28 | 12, 13 | 18, 21 | 7 | 16, 18 |
| 9 | 127 | KB | FGA (18) loss | 100 | X | 16 | 27, 28 | 12, 13 | 21 | 7 | 16, 18 |
| 10 | 183 | KB | FGA (18) loss | 100 | X | 16 | 27, 28 | 12, 13 | 21 | 7 | 16, 18 |
| 11 | 250 | Chang Liver | FGA (18) loss | 100 | X | 16 | 27, 28 | 12, 13 | 21 | 7 | 16, 18 |
| 12 | 233 | J-111 | D8 (13) loss | 100 | X | 16 | 27, 28 | 12 | 18, 21 | 7 | 16, 18 |
| 13 | 236 | HeLa.P3 | D21 (28) loss | 100 | X | 16 | 27 | 12, 13 | 18, 21 | 7 | 16, 18 |
| 14 | 242 | HMV-1 | D8 (13) loss vWF (19) gain | 91 | X | 16 | 27, 28 | 12 | 18, 21 | 7 | 16, 18, 19 |
| 15 | 256 | IMC-3 | D8 (13) loss vWF (18 to 19) change | 90 | X | 16 | 27, 28 | 12 | 18, 21 | 7 | 16, 19 |
| 16 | 223 | HeLa S3 | D21 (29) gain | 82 | X | 16 | 27, 28, 29 | 12 | 18, 21 | 7 | 17, 18 |
| D8 (13) loss | |||||||||||
| vWF (16 to 17) change | |||||||||||
amg, amelogenin.